All Infectious Disease articles – Page 3
-
NewsStudy maps how tuberculosis bacteria power themselves
A new study provides the first detailed 3D structure of a protein called EtfD, which the bacterium Mycobacterium tuberculosis uses to extract energy from lipids (fats), along with the first laboratory test capable of directly measuring its activity.
-
NewsClimate change is fueling disease outbreaks
Researchers analyzed the connection between a cyclone in Peru and a massive outbreak of dengue fever, a mosquito-borne viral disease that can cause fever, rash, and life-threatening symptoms like hemorrhage and shock. Their findings reveal that warmer, wetter weather linked to climate change is making disease epidemics more likely.
-
NewsLemongrass essential oil may target bacteria even more effectively than conventional antibiotics, research suggests
Lemongrass essential oil can be even more effective than traditional antibiotics against some Streptococcus bacteria under certain conditions, new research to be presented at MLSFF26 has found.
-
NewsWhat factors influence likelihood and severity of Ebola outbreaks?
Two new papers looked at factors that contribute to how Ebola outbreaks begin and how severe they become. This Q&A looks at how the results could inform public health interventions to prevent pathogen emergence or slow the spread of Ebola and other infectious diseases.
-
NewsTargeting two flu proteins sharply reduces airborne spread
A study in ferrets — which have remarkably similar respiratory systems to humans — suggests that immunity to two proteins in the H1N1 influenza virus sharply reduces transmission.
-
NewsTrial finds vitamin D supplements don’t reduce Covid severity but could reduce long COVID risk
In a large, randomized trial, researchers have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes.
-
NewsMothers' exposure to microbes protect their newborn babies against infection
A study dives into new depths to explore why only some babies develop severe infection to common bacteria. The research revealed that the babies that became most severely ill from E. coli infections also had markedly lower levels of germ-fighting antibodies transferred from their mothers.
-
NewsMedicinal plants with anti-entamoeba histolytica activity: phytochemistry, efficacy, and clinical potential
Reported adverse effects associated with the current first-line treatment for amoebiasis, coupled with the evolution of resistance to it, call for the need to search for plant-based alternatives. This study systematically reviews medicinal plants with activity against Entamoeba histolytica.
-
NewsScientists reveal how deadly Marburg virus enters human cells, identify therapeutic vulnerability
Researchers found that the Marburg virus, one of the world’s deadliest pathogens, is unusually efficient at getting inside human cells. They also showed that the virus’s entry protein contains structural features that explain this efficiency and point to a strategy for blocking infection.
-
NewsHow one flu virus can hamper the immune response to another
Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study.
-
NewsResearch guides response to unprecedented 2023 E. coli outbreak affecting Calgary kids
Protocols developed by scientists informed care when hundreds of children were sick due to a severe strain of E. coli. Overall, 40 children were hospitalized, 21 developed HUS and nine required dialysis. The number of children who developed HUS was less than half of what would typically occur in an outbreak of this size.
-
NewsTicks carrying more than one pathogen are on the rise in US Northeast
Tick-borne diseases are on the rise in the northeastern US, with many ticks carrying more than one pathogen. Most commonly found together were Borrelia burgdorferi and Babesia microti. Co-infection with these two pathogens was more frequent than expected, approaching 11% by the end of the study.
-
NewsWebinar: Unraveling periprosthetic joint infection
The free ‘Unraveling Periprosthetic Joint Infection’ webinar on March 25 explores one of the most challenging complications in modern orthopedic medicine, sitting at the intersection of microbiology, surgery, and patient care.
-
NewsSevere COVID-19 and flu facilitate lung cancer months or years later, new research shows
Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease’s development, but vaccination heads off those harmful effects, new research indicates.
-
NewsSeaweed has the potential to create a shield to block norovirus infection
Seaweed has certain properties which have the ability to create a shield within the human body, effectively blocking norovirus infection. Fucoidan, from brown seaweed, showed the strongest and most consistent blocking activity against two major norovirus strains, GII.4 and GII.17.
-
NewsBuilding protection against infectious diseases with nanostructured vaccines
Researchers have leveraged a recently developed highly versatile DNA origami nanotechnology that is both vaccine and adjuvant, named DoriVac, as an alternative to current vaccine platforms.
-
NewsRecent pandemic viruses jumped to humans without prior adaptation, study finds
A large-scale evolutionary analysis shows most zoonotic viruses emerge without prior adaptation, while passing through a laboratory leaves detectable genetic signatures, offering a new tool to interpret outbreak origins.
-
NewsMpox immune test validated during Rwandan outbreak
An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting.
-
NewsNew studies reveal how Clostridioides difficile behaves inside the body
Researchers studying C. diff at multiple levels, from how individual bacterial cells behave inside the gut to the molecular switches that help them survive and spread, are revealing hidden vulnerabilities.
-
NewsHerpes virus fluidizes cell nuclei to multiply faster
A new study finds that herpes simplex virus uses a protein called infected cell protein 4 (ICP4) to make the human nucleus more fluid-like, which in turn makes it easier for the virus to replicate itself. Blocking the ability of ICP4 to fluidize the nuclear compartment caused a drop in viral copy production.